SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-22-120912
Filing Date
2022-11-22
Accepted
2022-11-22 06:00:38
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 tm2230623-2_424b3.htm 424B3 453632
2 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 21874
3 GRAPHIC tm2230623d2-tbl_extern4clr.jpg GRAPHIC 79139
4 GRAPHIC tm2230623d2-tbl_materi4clr.jpg GRAPHIC 75909
5 GRAPHIC tm2230623d2-tbl_intern4clr.jpg GRAPHIC 174239
6 GRAPHIC tm2230623d2-tbl_early4clr.jpg GRAPHIC 133934
  Complete submission text file 0001104659-22-120912.txt   1123050
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262050 | Film No.: 221407372
SIC: 2834 Pharmaceutical Preparations